Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire, Amiens
Only few data are available about clinical management of phototherapy devices for the treatment of jaundice in the preterm infant.
This study is a prospective, monocentric, observational study. Preterm infant \< 35 weeks of gestation with a jaundice requiring phototherapy according to NICE guidelines can be included for the duration of the phototherapy treatment.
The decrease in bilirubin serum level before and after phototherapy treatment will be measured.
This decrease in bilirubin serum level will be assessed for two consecutive periods before and after an educational program on jaundice management of the preterm infant.
The investigators aim at demonstrating that an educational program could improve phototherapy management and result in a higher decrease in bilirubin serum during treatment of the preterm infant with jaundice.
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
preterm infant less than 35 weeks gestation
preterm infant hospitalized in the neonatal intensive care unit of CHU Amiens-Picardie
preterm infant placed in an incubator
preterm infant with a jaundice requiring treatment according to NICE guidelines
preterm infant with a no hemolytic disease
preterm infant with informed written consent from the parents
You may not be if
preterm infant more than 35 weeks of gestation
preterm infant with hemolytic disease
preterm infant with Jaundice related to a cholestasis